Downstaging Prediction Model for HCC
NCT07058649 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 369
Last updated 2025-07-10
Summary
This study is a real-world, single-center study that collects imaging and clinical data from patients with HCC who are downstaged beyond the UCSF criteria.
Conditions
- HCC - Hepatocellular Carcinoma
Sponsors & Collaborators
-
Beijing Tsinghua Chang Gung Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-16
- Primary Completion
- 2027-10-01
- Completion
- 2027-12-01
More Related Trials
-
The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions
NCT07055048 ·Status: NOT_YET_RECRUITING
-
Detect and Expunge Concealed Tumors of the Liver
NCT06141564 ·Status: ACTIVE_NOT_RECRUITING
-
Phenotyping Liver Cancer Registry
NCT04681274 ·Status: COMPLETED
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy
NCT01281683 ·Status: UNKNOWN
-
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
NCT04212286 ·Status: COMPLETED ·Phase: NA
-
Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients
NCT06577272 ·Status: RECRUITING
-
Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC
NCT04920214 ·Status: UNKNOWN
-
Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
NCT07059936 ·Status: RECRUITING
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
NCT04722120 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure
NCT05360420 ·Status: UNKNOWN ·Phase: NA
-
Relationship Between FGF19 Overexpression and Disease Prognosis
NCT06938451 ·Status: NOT_YET_RECRUITING
-
Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients
NCT06550739 ·Status: COMPLETED
-
Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma
NCT05327907 ·Status: UNKNOWN
-
The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment
NCT04299919 ·Status: UNKNOWN
-
Utility Study of Primovist-MRI on HCC Staging
NCT01764438 ·Status: UNKNOWN
-
Prospective Surveillance for Very Early Hepatocellular Carcinoma
NCT03588442 ·Status: UNKNOWN
-
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
NCT00912847 ·Status: COMPLETED
-
Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma
NCT07030842 ·Status: COMPLETED
-
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients
NCT04802954 ·Status: COMPLETED ·Phase: NA
-
"Double Low-Dose" DECT for HCC Imaging
NCT03045445 ·Status: COMPLETED ·Phase: NA
-
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
NCT01116804 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS
NCT06590948 ·Status: RECRUITING
-
Role of CEUS as a Secondary Diagnostic Modality
NCT04494022 ·Status: UNKNOWN ·Phase: NA